ESAB (NYSE:ESAB) announced on Monday a definitive agreement to acquire Eddyfi Technologies for $1.45 billion, marking a significant strategic pivot into the advanced non-destructive testing (NDT) and structural integrity market.
Eton Pharmaceuticals (NASDAQ:ETON) announced on Monday that it has secured U.S. marketing rights for a new ultra-rare disease product candidate, further cementing its position in the specialized orphan drug market.
Dublin-based Aptiv (NYSE:APTV), a global technology company focused on enabling a more automated, electrified, and digitalized future, today reported record financial results for the fourth quarter and full year ended December 31, 2025.
Fifth Third Bancorp (NASDAQ:FITB) finalized its merger with Comerica Incorporated on Monday, creating a regional banking powerhouse with approximately $294 billion in assets.
IDEXX Laboratories (NASDAQ:IDXX) reported fourth-quarter earnings that surpassed analyst expectations, fueled by double-digit growth in its core companion animal business and significant margin expansion.
FEMSA (NYSE:FMX) finalized the separation of its Grupo Nós joint venture with Raízen on Monday, resulting in FEMSA assuming 100% ownership of OXXO Brazil.
Natera (NASDAQ:NTRA) submitted a formal application for U.S. regulatory approval of its Signatera molecular residual disease test as a companion diagnostic for bladder cancer, moving to solidify its lead in the burgeoning field of precision oncology.
Revvity (NYSE:RVTY) reported fourth-quarter and full-year 2025 results on Monday that exceeded Wall Street estimates, bolstered by resilient demand across its life sciences and diagnostics portfolios.
Patria Investments (NASDAQ:PAX) reached a deal to acquire WP Global Partners on Monday, a move that significantly bolsters the firm’s presence in the U.S. lower-middle market.
Arthur J. Gallagher (NYSE:AJG) bolstered its international risk management division on Monday, announcing that its subsidiary Gallagher Bassett has acquired Bremen, Germany-based Reck & Co. GmbH.
Mizuho Financial Group (NYSE:MFG) reported fiscal third-quarter earnings that surpassed Wall Street expectations, as Japan’s third-largest lender benefited from a favorable interest rate environment and steady corporate lending activity.
Alvotech (NASDAQ:ALVO) solidified its global commercialization strategy on Monday, entering into new supply and marketing agreements with Sandoz to bring a suite of biosimilar candidates to Canada, Australia, and New Zealand.
